razoxane has been researched along with Kidney Diseases in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bárdi, E; Bobok, I; Kappelmayer, J; Kiss, C; V Oláh, A | 1 |
Carrano, RA; Imondi, AR; Perkins, WE; Schroeder, RL | 1 |
Ferrans, VJ; Herman, EH; Zhang, J | 1 |
Catimel, G; Clavel, M; Merrouche, Y | 1 |
Clark, JR; Ferrans, VJ; Herman, EH; Zhang, J | 1 |
Chadwick, DP; Ferrans, VJ; Herman, EH; Zhang, J | 1 |
Baba, H; Bull, JM; Newman, RA; Ohno, S; Siddik, ZH; Stephens, LC; Strebel, FR | 1 |
el-Hage, A; Ferrans, VJ; Herman, EH | 1 |
1 review(s) available for razoxane and Kidney Diseases
Article | Year |
---|---|
Hematopoietic growth factors and chemoprotectants: should we move toward a two-step process for phase I clinical trials in oncology?
Topics: Antineoplastic Agents; Clinical Trials, Phase I as Topic; Heart Diseases; Hematopoietic Cell Growth Factors; Humans; Kidney Diseases; Neoplasms; Neutropenia; Razoxane | 1993 |
7 other study(ies) available for razoxane and Kidney Diseases
Article | Year |
---|---|
Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer.
Topics: Acetylglucosaminidase; Adolescent; Adult; Albuminuria; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Child; Child, Preschool; Creatinine; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Idarubicin; Infant; Kidney Diseases; Kidney Tubules, Proximal; Lymphoma, Non-Hodgkin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Retrospective Studies | 2007 |
Effect of ICRF-187 on doxorubicin-induced myocardial effects in the mouse and guinea pig.
Topics: Animals; Cardiomyopathies; Doxorubicin; Female; Guinea Pigs; Heart Rate; Histamine; Kidney Diseases; Male; Mice; Mice, Inbred ICR; Myocardial Contraction; Piperazines; Razoxane; Stereoisomerism | 1982 |
Comparison of the protective effects of desferrioxamine and ICRF-187 against doxorubicin-induced toxicity in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Cardiomyopathies; Deferoxamine; Doxorubicin; Heart Rate; Injections, Intraperitoneal; Injections, Intravenous; Kidney Diseases; Male; Rats; Rats, Inbred SHR; Razoxane | 1994 |
Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187.
Topics: Animals; Apoptosis; Cardiomyopathies; Cardiovascular Agents; Dose-Response Relationship, Drug; Doxorubicin; Heart; Hypertension; Immunohistochemistry; Intestines; Iron Chelating Agents; Kidney; Kidney Diseases; Male; Microscopy, Electron; Myocardium; Rats; Rats, Inbred SHR; Razoxane | 1996 |
Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats.
Topics: Amifostine; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Body Weight; Doxorubicin; Heart Diseases; Hypertension; Kidney; Kidney Diseases; Male; Myocardium; Radiation-Protective Agents; Rats; Rats, Inbred SHR; Razoxane | 2000 |
Protective effect of ICRF-187 against normal tissue injury induced by adriamycin in combination with whole body hyperthermia.
Topics: Animals; Blood Cell Count; Body Weight; Combined Modality Therapy; Doxorubicin; Female; Heart Diseases; Hematopoiesis; Hyperthermia, Induced; Kidney Diseases; Nervous System Diseases; Rats; Rats, Inbred F344; Razoxane; Sarcoma, Experimental; Survival Analysis | 1991 |
Protective effect of ICRF-187 on doxorubicin-induced cardiac and renal toxicity in spontaneously hypertensive (SHR) and normotensive (WKY) rats.
Topics: Animals; Blood Pressure; Body Weight; Doxorubicin; Drug Interactions; Heart Diseases; Heart Rate; Kidney Diseases; Male; Piperazines; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Razoxane; Species Specificity | 1988 |